Skip to main content
Log in

First Experience with Banded Anti-reflux Mucosectomy (ARMS) for GERD: Feasibility, Safety, and Technique (with Video)

  • Multimedia Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

Anti-reflux mucosectomy (ARMS) is a relatively new endoscopic procedure for gastroesophageal reflux disease (GERD). A hemi-circumferential endoscopic mucosal resection (EMR) is performed around the gastroesophageal junction (GEJ), which then contracts and tightens during healing. The aim of this study was to assess the feasibility and safety of the procedure. A secondary aim was to assess short-term outcomes on PPI use and symptom resolution.

Methods

IRB approval was obtained for retrospective review of a prospectively collected database including patients who underwent ARMS during a 2-year period. To be eligible for the procedure, patients required medically refractory GERD and a hiatal hernia no more than 2 cm. A 270-degree mucosal resection of the gastric cardia was performed in a retroflexed position using a multi-band EMR system. Demographics, preoperative workup, intraoperative factors, additional procedures, and other follow-up were collected by chart review. Voluntary validated surveys assessed symptomatic improvement over time.

Results

There were 19 patients available for review. The procedure was technically completed in all cases. There was one muscle injury due to a deep resection that was repaired by endoscopic suturing. All patients were discharged on the day of the procedure. Early dysphagia was experienced by three patients (16%) which was addressed with endoscopic balloon dilation. GERD symptoms improved in 13 patients (68%) after discontinuing PPI therapy. Three of the six failures went on to have additional anti-reflux surgery. Among patients who did not have additional surgery, quality of life data showed significant symptomatic improvement by 6 months.

Conclusion

In this ARMS case series, the procedure was technically successful in all patients with only one minor complication. Two thirds of patients showed symptomatic improvement and were able to discontinue their PPI. ARMS appears to be a safe procedure that does not hinder future laparoscopic anti-reflux surgery in case of failure. Additional tuning of technique and postoperative management may be able to reduce dysphagia rates and the need for dilation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gawron AJ, French DD, Pandolfino JE et al. Economic evaluations of gastroesophageal reflux disease medical management. Pharmacoeconomics 2014; 32:745–758.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Brasseur JG, Ulerich R, Dai Q et al. Pharmacological dissection of the human gastro-oesophageal segment into three sphincteric components. J Physiol 2007; 580: 961–975.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Menezes MA, Herbella FA. Pathophysiology of gastroesophageal reflux disease. World J Surg 2017; 41: 1661–1671.

    Article  Google Scholar 

  4. Reimer C. Safety of long-term PPI therapy. Best Pract Res Clin Gastroenterol. 2013;27(3):443–54.

    Article  CAS  PubMed  Google Scholar 

  5. Witteman BP, Conchillo JM, Rinsma NF et al. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibi-tors for treatment of gastroesophageal reflux disease. Am J Gastroenterol 2015; 110: 531–542.

    Article  CAS  PubMed  Google Scholar 

  6. Ozawa S, Kumai K, Higuchi K et al. Short-term and long-term outcome of endoluminal gastroplication for the treatment of GERD: the first multicenter trial in Japan. J Gastroenterol 2009; 44: 675–684.

    Article  PubMed  Google Scholar 

  7. Satodate H, Inoue H, Yoshida T, et al. Circumferential EMR of carcinoma arising in Barrett's esophagus: case report. Gastrointest Endosc. 2003;58:288–292.

    Article  PubMed  Google Scholar 

  8. Inoue H, Ito H, Ikeda H, Sato C, Sato H, Phalanusitthepha C, Hayee B, Eleftheriadis N, Kudo SE. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol. 2014;27(4):346–351.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Herbert Mason Hedberg.

Ethics declarations

Conflict of Interest

Dr. Hedberg and Ms. Kuchta have no conflicts of interest to disclose. Dr. Ujiki receives consulting fees from GORE, Boston Scientific, Apollo Endosurgery, Olympus, and Medtronic, none directly related to the submitted work.

Disclaimers

The views expressed in the submitted article are the authors’ own and not an official position of their respective institutions.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hedberg, H.M., Kuchta, K. & Ujiki, M.B. First Experience with Banded Anti-reflux Mucosectomy (ARMS) for GERD: Feasibility, Safety, and Technique (with Video). J Gastrointest Surg 23, 1274–1278 (2019). https://doi.org/10.1007/s11605-019-04115-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-019-04115-1

Keywords

Navigation